Parag Jhaveri
Principal at Paladin Capital Group
San Francisco, California
Overview
Work Experience
Founder & CEO
2022 - Current
Building Healthcare Administration General Intelligence (HAGI) company.
Board Observer
2023
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Raised $47,000,000.00 from FusionX Ventures, Vertical Venture Partners, Illumina Ventures, Warburg Pincus, Casdin Capital, Sagian Equity and Anzu Partners.
Board Observer
2023
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Raised $6,067,053.00 from +ND Capital, Vertical Venture Partners and Paladin Capital Group.
Board Observer
2022
Cellsonics is setting new standards with single-cell sample preparation.
Principal
2022
Venture Capitalist
2021
VC23 is an investment management company that finds, analyzes, and structures venture capital investments in companies.
Raised $2,751,528.00.
Investor
2022
Codetta Bio is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.
Raised $29,280,996.00 from Collaboratory.
Investor | Late Stage Growth
2022
Menlo Micro is the developer of the Ideal Switch, an electromechanical switch technology used to switch AC/DC and RF.
Raised $227,500,000.00 from Piva Capital, Paladin Capital Group, PeopleFund, Lakewood & Company, Adage Capital Management, Future Shape, Fidelity, DBL Partners and Vertical Venture Partners.
Investor | Late Stage Growth
2021
Investor
2021